Capital Fund Management S.A. Global Blood Therapeutics, Inc. Transaction History

Capital Fund Management S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$22.3 - $37.39 $174,631 - $292,801	7,831 Added 8.22%	103,138 $3.3 Million
Q1 2022 May 12, 2022	BUY	$25.68 - $35.59 $2.13 Million - $2.95 Million	82,986 Added 673.53%	95,307 $3.3 Million
Q4 2021 Feb 10, 2022	SELL	$24.9 - $40.26 $65,337 - $105,642	-2,624 Reduced 17.56%	12,321 $360,000
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $203,941 - $298,869	8,004 Added 115.31%	14,945 $380,000
Q4 2019 Feb 13, 2020	BUY	$45.7 - $81.86 $106,435 - $190,651	2,329 Added 50.5%	6,941 $552,000
Q3 2019 Nov 13, 2019	BUY	$45.35 - $57.91 $209,154 - $267,080	4,612 New	4,612 $224,000
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $1.4 Million - $2.07 Million	-44,413 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $1.69 Million - $2.27 Million	44,413 New	44,413 $1.69 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.